Remove 2007 Remove Diabetes Remove Illness Remove Patients
article thumbnail

Biased research, aggressive sales, harmful drugs

The Health Policy Exchange

In this month's Georgetown University Health Policy seminar, we discussed two examples, anemia drugs and the diabetes drug rosiglitazone (Avandia) , which were prominently featured in recent articles by Peter Whoriskey in The Washington Post. for three more years, during which thousands of new patients were prescribed the drug.

article thumbnail

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

GeriPal

I tell this story because these issues don’t typically register as more than a nuisance for clinicians, who frequently don’t understand why their older patient with osteoporosis is not taking a bisphosphonate. But our patients are walking with their feet, and adherence to bisphosphonates for osteoporosis is poor and decreases with time.

Clinic 67